Rapport Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Rapport Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2023 to Q2 2025.
  • Rapport Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2025 was 36.5M shares, a 0.22% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 36.5M -78.8K -0.22% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 36.5M Mar 31, 2025 10-Q 2025-05-08
Q4 2024 36.6M +32.4M +777% Dec 31, 2024 10-Q 2025-08-07
Q3 2024 36.6M Sep 30, 2024 10-Q 2024-11-07
Q2 2024 36.6M Jun 30, 2024 10-Q 2024-08-08
Q4 2023 4.17M Dec 31, 2023 10-K 2025-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.